ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 291

Illness Features Associated with an Increased Risk of Mortality in Children with Juvenile Idiopathic Inflammatory Myopathies

Adam M. Huber1, Gulnara Mamyrova2, Julia A. Lee3, Peter A. Lachenbruch4, Ira N. Targoff5, Frederick W. Miller4, Lisa G. Rider4 and Childhood Myositis Heterogeneity Study Group6, 1Dalhousie University, Halifax, NS, Canada, 2Rheumatology, George Washington University, Washington, DC, 3Environmental Autoimmunity Grp, NIEHS, Bethesda, MD, 4Environmental Autoimmunity Group, NIEHS, NIH, Bethesda, MD, 5Arthritis and Immunology, Oklahoma Medical Research Foun, Oklahoma City, OK, 6Bethesda, MD

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: juvenile dermatomyositis, juvenile myositis, morbidity and mortality, myositis and pediatric rheumatology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects: Pediatric Systemic Lupus Erythematosus, Pediatric Vasculitis and Pediatric Myositis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Juvenile idiopathic inflammatory myopathies (JIIM) are potentially life-threatening systemic autoimmune diseases but little in known regarding factors associated with mortality.

Methods: Patients enrolled in a nationwide registry which included demographics, clinical and laboratory features, and outcomes. Timing of features (at diagnosis, after diagnosis or ever) was recorded. Mortality status was available for 419/441 (95%) patients (342 juvenile dermatomyositis (JDM), 30 juvenile polymyositis (JPM) and 47 juvenile connective tissue disease associated myositis (JCTM)), based on the Social Security Death Index or physician report. Poisson regression was used to assess univariable associations with mortality. Random survival forest classification followed by Poisson regression was used to assess multivariable associations.

Results: The cohort was 74% female, 69% white, median diagnosis age 7.6 years and median follow-up 4.3 years. There were 17 deaths (4%): 7 pulmonary (interstitial lung disease [ILD]), 3 gastrointestinal (perforation or hemorrhage), 3 multisystem (sepsis, multi-organ failure) and 4 unknown.

For univariable analysis, features present at diagnosis associated with an increased risk of death (P<0.05) were disease subgroup (mortality 2.3% JDM, 6.7% JPM, 14.9% JCTM), hospitalization, onset severity, younger age at diagnosis, anti-synthetase, anti-Ku or -La autoantibodies, dysphagia, abdominal perforation, Raynaud’s phenomenon, ILD, shawl sign rash, gastroesophageal reflux and dysphonia. Features present after diagnosis associated with an increased risk of death were wheelchair use at last assessment, ILD, fever, pneumothorax or pneumomediastinum, abdominal perforation and number of hospitalizations. For features present at any time, including unknown timing, additional features associated with increased risk of death included syncope, dyspnea, sclerodactyly, weight loss, and decreased risk: fatigue, Gottron’s papules and linear extensor erythema. Multivariable analyses revealed the following:

 

MULTIVARIABLE ANALYSIS

 

Incidence Rate Ratio

P-value

Features present at time of diagnosis

 

 

 

 

Raynaud’s phenomenon

10.2

0.000

 

Onset severity

3.8

0.01

Features present after diagnosis

 

 

 

 

Wheelchair use at last assessment

11.3

0.000

 

ILD

5.1

0.004

 

Any anti-synthetase autoantibody

4.4

0.02

Features present at any time

 

 

 

 

Fatigue

0.02

0.000

 

ILD

12.8

0.001

 

Weight loss

5.9

0.04

Conclusion: We have identified illness features associated with an increased risk of death in a large JIIM cohort. Some, such as ILD, anti-synthetase autoantibodies and Raynaud’s, extend to JIIM the factors that have been associated with mortality in adult disease.  Others, such weight loss, severity at onset, and fatigue (protective) are novel to this JIIM cohort. These results warrant further study in additional cohorts to confirm their predictive value.


Disclosure:

A. M. Huber,
None;

G. Mamyrova,
None;

J. A. Lee,
None;

P. A. Lachenbruch,
None;

I. N. Targoff,
None;

F. W. Miller,
None;

L. G. Rider,
None;

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/illness-features-associated-with-an-increased-risk-of-mortality-in-children-with-juvenile-idiopathic-inflammatory-myopathies/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology